Clinical Trial Update: Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing AZD9567 to prednisolone for efficacy and safety in rheumatoid arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD9567 (AZD9567)
• Prednisolone (Prednisolone)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-10-05